338 related articles for article (PubMed ID: 25685910)
1. Inhibitors of the AAA+ chaperone p97.
Chapman E; Maksim N; de la Cruz F; La Clair JJ
Molecules; 2015 Feb; 20(2):3027-49. PubMed ID: 25685910
[TBL] [Abstract][Full Text] [Related]
2. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
[TBL] [Abstract][Full Text] [Related]
3. Structure and functions of the chaperone-like p97/CDC48 in plants.
Bègue H; Jeandroz S; Blanchard C; Wendehenne D; Rosnoblet C
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3053-3060. PubMed ID: 27717811
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of the AAA+ ATPase p97/Cdc48p.
Xia D; Tang WK; Ye Y
Gene; 2016 May; 583(1):64-77. PubMed ID: 26945625
[TBL] [Abstract][Full Text] [Related]
5. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus.
Rutledge AC; Qiu W; Zhang R; Kohen-Avramoglu R; Nemat-Gorgani N; Adeli K
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):579-85. PubMed ID: 19164805
[TBL] [Abstract][Full Text] [Related]
7. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.
Niwa H; Ewens CA; Tsang C; Yeung HO; Zhang X; Freemont PS
J Biol Chem; 2012 Mar; 287(11):8561-70. PubMed ID: 22270372
[TBL] [Abstract][Full Text] [Related]
8. Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.
Auner HW; Moody AM; Ward TH; Kraus M; Milan E; May P; Chaidos A; Driessen C; Cenci S; Dazzi F; Rahemtulla A; Apperley JF; Karadimitris A; Dillon N
PLoS One; 2013; 8(9):e74415. PubMed ID: 24069311
[TBL] [Abstract][Full Text] [Related]
9. Evaluating p97 Inhibitor Analogues for Potency against p97-p37 and p97-Npl4-Ufd1 Complexes.
Gui L; Zhang X; Li K; Frankowski KJ; Li S; Wong DE; Moen DR; Porubsky PR; Lin HJ; Schoenen FJ; Chou TF
ChemMedChem; 2016 May; 11(9):953-7. PubMed ID: 27043824
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional implications of phosphorylation and acetylation in the regulation of the AAA+ protein p97.
Ewens CA; Kloppsteck P; Förster A; Zhang X; Freemont PS
Biochem Cell Biol; 2010 Feb; 88(1):41-8. PubMed ID: 20130678
[TBL] [Abstract][Full Text] [Related]
11. Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants.
Tang WK; Xia D
J Biol Chem; 2013 Dec; 288(51):36624-35. PubMed ID: 24196964
[TBL] [Abstract][Full Text] [Related]
12. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system.
Meyer H; Bug M; Bremer S
Nat Cell Biol; 2012 Feb; 14(2):117-23. PubMed ID: 22298039
[TBL] [Abstract][Full Text] [Related]
13. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
Kobayashi T; Tanaka K; Inoue K; Kakizuka A
J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
[TBL] [Abstract][Full Text] [Related]
14. UBXD1 binds p97 through two independent binding sites.
Kern M; Fernandez-Sáiz V; Schäfer Z; Buchberger A
Biochem Biophys Res Commun; 2009 Mar; 380(2):303-7. PubMed ID: 19174149
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in p97/VCP/Cdc48 cellular functions.
Yamanaka K; Sasagawa Y; Ogura T
Biochim Biophys Acta; 2012 Jan; 1823(1):130-7. PubMed ID: 21781992
[TBL] [Abstract][Full Text] [Related]
16. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation.
Rabinovich E; Kerem A; Fröhlich KU; Diamant N; Bar-Nun S
Mol Cell Biol; 2002 Jan; 22(2):626-34. PubMed ID: 11756557
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases.
Valimehr S; Sethi A; Shukla M; Bhattacharyya S; Kazemi M; Rouiller I
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238606
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of the PLAA/Ufd3-p97/Cdc48 complex.
Qiu L; Pashkova N; Walker JR; Winistorfer S; Allali-Hassani A; Akutsu M; Piper R; Dhe-Paganon S
J Biol Chem; 2010 Jan; 285(1):365-72. PubMed ID: 19887378
[TBL] [Abstract][Full Text] [Related]
19. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
20. A Fragment-Based Ligand Screen Against Part of a Large Protein Machine: The ND1 Domains of the AAA+ ATPase p97/VCP.
Chimenti MS; Bulfer SL; Neitz RJ; Renslo AR; Jacobson MP; James TL; Arkin MR; Kelly MJ
J Biomol Screen; 2015 Jul; 20(6):788-800. PubMed ID: 25690569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
